Log in

Follow-Up of Patients with Interventional Closure of Ventricular Septal Defects with Amplatzer Duct Occluder II

  • Original Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Nonsurgical closure of congenital ventricular septal defects (VSD) has become increasingly acceptable with the availability of different occlusion systems. Transcatheter device treatment is used for perimembranous and muscular defects. Atrio-ventricular block remains the most troublesome complication of device closure. The aim of this study was to describe our experience with closure of VSD using the Amplatzer Duct Occluder II (ADO II) as an “off-label” approach in children and adults. Between 2004 and 2012 transcatheter closure of 31 VSD (20 perimembranous, 10 muscular VSD and 1 ruptured sinus valsalva) with ADO II was undertaken in patients between 3 months and 55 years of age and with a body weight ranging from 4 to 105 kg in our institution. In 29 of 31 procedures, the defect was successfully closed (93.5 %) without any significant complications. No increase of aortic or tricuspid valve regurgitation was found in any after procedure. Small residual shunts were observed immediately after the device implantation, but disappeared during a median follow-up period of 38 months (0.4–63) in 27 of 31 patients. There was no incidence of AV block or other conductance abnormalities during implantation or follow-up. The ADO II device is safe and effective for transcatheter VSD closure, but this is still an “off-label” use. After long-term follow-up in a large number of patients this device may be approved for VSD closure in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Arora R, Trehan V, Kumar A (2003) Transcatheter closure of congenital ventricular septal defects. Experience with various devices. J Interv Cardiol 16:83–91

    Article  PubMed  Google Scholar 

  2. Bass JL, Gruenstein D (2012) Transcatheter closure of the perimembranous ventricular septal defect-preclinical trial of a new Amplatzer device. Catheter Cardiovasc Interv 79(7):1153–1160. doi:10.1002/ccd.23367 Epub 2011 Dec 12

    Article  PubMed  Google Scholar 

  3. Bass JL, Kalra GS, Arora R et al (2003) Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Cathet Cardiovasc Intervent 58:238–245

    Article  Google Scholar 

  4. Benton JP, Barker KS (1992) Transcatheter closure of ventricular septal defect: anonsurgical approach to the care of the patient with acute ventricular septal rupture. Heart Lung 4:356–364

    Google Scholar 

  5. Bol-Raap G, Weerheim J, Kappetein AP, Witsenburg M, Bogers AJ (2003) Follow-up after surgical closure of congenital ventricular septal defects. Eur J Cardiothorac Surg 24:511–515

    Article  CAS  PubMed  Google Scholar 

  6. Butera G, Chessa M, Piazza L, Negura D, Micheletti A, Carminati M (2006) Percutaneous closure of ventricular septal defects. Expert Rev Cardiovasc Ther. 4(5):671–680 Review

    Article  PubMed  Google Scholar 

  7. Butera G, Carminati M, Chessa M et al (2006) Percutaneous closure of ventricular septal defects in children aged b 12: early and midterm results. Eur Heart J 27(23):2889–2895

    Article  PubMed  Google Scholar 

  8. Butera G, Carminati M, Chessa M, Piazza L, Micheletti A, Negura DG, Abella R, Giamberti A, Frigiola A (2007) Transcatheter closure of perimembranous ventricular septal defects: early and long-term results. J Am Coll Cardiol 50(12):1189–1195

    Article  PubMed  Google Scholar 

  9. Chessa M, Carminati M, Butera G et al (2002) Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 39:1061–1065

    Article  PubMed  Google Scholar 

  10. Hijazi ZM, Hakim F, Al Fadley F, Abdelhamid J, Cao QL (2000) Transcatheter closure of single muscular ventricular septal defects using the Amplatzer muscular VSD occluder: initial results and technical considerations. Catheter Cardiovasc Intervent 49:167–172

    Article  CAS  Google Scholar 

  11. Hijazi ZM, Hakim F, Haweleh AA et al (2002) Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience. Cathet Cardiovasc Interv 56:508–515

    Article  Google Scholar 

  12. Hobbins SM, Izukawa T, Radford DJ, Williams WG, Trusler GA (1979) Conduction disturbances after surgical correction of ventricular septal defect by the atrial approach. Br Heart J 41:289–293

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Holzer R, Balzer D, Qi-Ling C, Lock K, Hijazi ZM, Amplatzer Muscular Ventricular Septal Defect Investigators (2004) Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder. J Am Coll Cardiol 43:1257–1263

    Article  PubMed  Google Scholar 

  14. Holzer R, de Giovanni J, Walsh KP et al (2006) Transcatheter closure of perimem-branous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry. Catheter Cardiovasc Interv 68:620–628

    Article  PubMed  Google Scholar 

  15. Janorkar S, Goh T, Wilkinson J (1999) Transcatheter closure of ventricular septal defects using the Rashkind device: initial experience. Catheter Cardiovasc Interv 1:43–48

    Article  Google Scholar 

  16. Kalra GS, Verma PK, Dhall A et al (1999) Transcatheter device closure of ventricular septal defects: Immediate results and intermediate-term follow-up. Am Heart J 2(Pt 1):339–344

    Article  Google Scholar 

  17. Kidd L, Discroll DJ, Gersony WH et al (1993) Second natural history study of congenital heart defects: results of treatment of patients with ventricular septal defects. Circulation 87(Suppl I):138–151

    Google Scholar 

  18. Kirklin JW, Barrat-Boyes BG (1993) Ventricular septal defect. In: Kouchoukos NT, Blacksgowe EH, Doty DB, Hawley FL, Karp RB (eds) Cardiac surgery, 3rd edn. Churchill Livingstone, New York, pp 850–910

    Google Scholar 

  19. Koneti NR, Sreeram N, Penumatsa RR, Arramraj SK, Karunakar V, Trieschmann U (2012) Transcatheter retrograde closure of perimembranous ventricular septal defects in children with the Amplatzer duct occluder II device. J Am Coll Cardiol. 60(23):2421–2422. doi:10.1016/j.jacc.2012.08.1004 Epub 2012 Nov 7

    Article  PubMed  Google Scholar 

  20. Latiff HA, Alwi M, Kandhavel G et al (1999) Transcatheter closure of multiple muscular ventricular septal defects using Gianturco coils. Ann Thorac Surg 4:1400–1401

    Article  Google Scholar 

  21. Lock JE, Block PC, McKay RG et al (1988) Transcatheter closure of ventricular septal defects. Circulation 2:361–368

    Article  Google Scholar 

  22. Mavroudis C, Backer CL, Jacobs JP (2003) Ventricular septal defect. Pediatric cardiac surgery, 3rd edn. Mosby, Philadelphia, pp 298–320

    Google Scholar 

  23. Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE (2004) Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial. J Am Coll Cardiol 44:513–519

    Article  PubMed  Google Scholar 

  24. Pedra AC, Pedra SRF, Esteves CA et al (2004) Percutaneous closure of peri-membranous ventricular septal defects with the Amplatzer device: technical and morphological considerations. Cathet Cardiovasc Interv 61:403–410

    Article  Google Scholar 

  25. Predescu D, Chaturvedi RR, Friedberg MK, Benson LN, Ozawa A, Lee KJ (2008) Complete heart block associated with device closure of perimembranous ventricular septal defects. J Thorac Cardiovasc Surg 136:1223–1228

    Article  PubMed  Google Scholar 

  26. Ramakrishnan S, Saxena A, Choudhary SK (2011) Residual VSD closure with an ADO II device in an infant. Congenit Heart Dis 6(1):60–63. doi:10.1111/j.1747-0803.2010.00468

    Article  PubMed  Google Scholar 

  27. Rigby ML, Redington AN (1994) Primary transcatheter umbrella closure of peri-membranous ventricular septal defect. Br Heart J 4:368–371

    Article  Google Scholar 

  28. Zhao PJ, Yu ZQ, Gao W, Li F, Fu LJ, Liu TL, Li Y, Zhang YQ, Huang MR, Guo Y (2012) Efficacy of the transcatheter closure of perimembranous and muscular ventricular septal defects with the Amplatzer duct occluder II. Zhonghua **n Xue Guan Bing Za Zhi 40(10):817–820

    PubMed  Google Scholar 

Download references

Conflict of interest

Peter Ewert and Felix Berger are consultants for St. Jude Medical. All other authors have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Schubert.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kanaan, M., Ewert, P., Berger, F. et al. Follow-Up of Patients with Interventional Closure of Ventricular Septal Defects with Amplatzer Duct Occluder II. Pediatr Cardiol 36, 379–385 (2015). https://doi.org/10.1007/s00246-014-1017-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-014-1017-0

Keywords

Navigation